A Case of Vasculitis in Chronic Hepatitis C Patient Treated with Pegylated Interferon Alpha-2a and Ribavirin / 대한간학회지
The Korean Journal of Hepatology
;
: 419-422, 2007.
Article
in Korean
| WPRIM
| ID: wpr-212151
ABSTRACT
There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN plus ribavirin combination therapy are bone marrow suppression and hemolytic anemia. However, there are few reports of vasculitis occurring during PEG-IFN therapy. We describe a patient who developed vasculitis during the treatment of chronic hepatitis C with PEG-IFN and ribavirin.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Antiviral Agents
/
Polyethylene Glycols
/
Ribavirin
/
Skin
/
Vasculitis
/
Hepatitis C, Chronic
/
Drug Therapy, Combination
/
Interferon alpha-2
/
Liver Function Tests
Limits:
Female
/
Humans
Language:
Korean
Journal:
The Korean Journal of Hepatology
Year:
2007
Type:
Article
Similar
MEDLINE
...
LILACS
LIS